Make appointment
Portada_hepatitis

Blog

Get the latest news about liver diseases and more

| News | Treatments
Treatment of pruritus in primary biliary cholangitis

Linerixibat, a bile acid transport inhibitor, has shown significant benefits in the treatment of pruritus in primary biliary cholangitis, reducing itching and improving sleep with minimal side effects.

| Fatty liver | News | Treatments
Research of a new drug for fatty liver

A promising new treatment for fatty liver disease has outperformed existing medications like Ozempic and Mounjaro in reducing liver fat, according to a recent study presented at a major liver disease conference.

| Hepatitis B | News | Treatments
Development of a new drug for the treatment of Hepatitis B virus

Hepalatide, used with pegylated interferon-alpha, shows promise for curing chronic hepatitis B by eliminating cccDNA from liver cells, according to early study results presented in a European liver congress.

| Fatty liver | News | Treatments
Efficacy of resmetirom in clinical practice and side effects

Resmetirom is the first approved drug for steatohepatitis, effective in reducing liver fat and fibrosis. Available in the U.S., it awaits approval in Europe due to high cost and limited access.

| Fatty liver | News | Treatments
Efimosfermin-alfa: New drug for fatty liver

Efimosfermin-alfa shows promise as a treatment for fatty liver disease, improving fibrosis and inflammation with monthly dosing, according to early clinical study results.

| Diseases | News | Treatments
Benefits of statins for liver diseases

A JAMA study shows that statins may benefit liver disease patients by lowering liver cancer risk, reducing complications, and improving fibrosis, especially with lipophilic and hydrophilic statins.

| Diseases | Fatty liver | Healthy nutrition
Fatty liver disease prevention

Fatty liver disease prevention involves healthy diets, intermittent fasting, regular exercise, coffee intake, and limiting sugars and saturated fats. These actions help reduce liver fat and disease risk.

| Fatty liver | News
Relationship between fatty liver and kidney and gallbladder stones

Research indicates a potential relationship between fatty liver, kidney stones, and gallstones due to shared metabolic risk factors. More studies are required to validate these findings across different populations.

1 2 3 … 16
Artículos destacados
Card image cap
Liver and diet (I)

27 de October de 2019

Ver más
Card image cap
Ver más
Card image cap
Ver más
Categorías
Card image cap
Hidden infection by C virus

Up to 30% of patients with cryptogenic hepatitis can be caused by the seronegative hidden infection by hepatitis C virus (HIC).

Saber más
Card image cap
Cryptogenic Hepatitis

It is a liver disease of an inflammatory nature and can develop chronically.

Saber más
Card image cap
Hepatitis C

Hepatitis is an inflammation of the liver, and in the case of hepatitis C, caused by infection with hepatitis C virus (HCV)

Saber más
Card image cap
Hepatitis E

Hepatitis E is an acute inflammatory disease of the liver that can lead to fulminant hepatitis.

Saber más
Card image cap
Hepatitis A

Hepatitis A is an acute inflammatory disease of the liver, caused by infection with hepatitis A virus (VAH).

Saber más
Card image cap
Hepatitis B

It is a viral infection of the liver that causes inflammation of the liver and the death of hepatocytes.

Saber más
Ver todas

Calle Guzmán el Bueno, 72. 28015 - Madrid

91 544 94 64
91 544 60 13

Open: Monday to Friday
09:00 a 18:00

About Us

The Foundation for the Study of Viral Hepatitis is a benchmark in the field of hepatology worldwide, with the best specialists in liver diseases and molecular biology. A clinic specialized in internal medicine, liver and digestive system in Madrid

Links of interest

Latest Posts

Treatment of pruritus in primary biliary cholangitis

Research of a new drug for fatty liver

Development of a new drug for the treatment of Hepatitis B virus
© 2018 - 2025 FEHV Clinic. All rights reserved.  Privacy Policy.  Cookies Policy.  Legal Notice.